Status:

COMPLETED

Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use

Lead Sponsor:

H. Lundbeck A/S

Conditions:

Schizophrenia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of the study is to determine whether there is an increased all-cause mortality in sertindole-treated patients in comparison to patients treated with a well-known antipsychotic (risperidone...

Detailed Description

The Committee for Medicinal Products for Human Use (CHMP) requested a post-marketing study to ascertain that the favourable benefit-risk profile and low mortality rates seen in the clinical studies wi...

Eligibility Criteria

Inclusion

  • The patient has signed the Informed Consent Form or, if he/she is not able to sign it (according to the ICH GCP guidelines and the Declaration of Helsinki), the patient's legal representative has signed the Informed Consent Form
  • The patient has been diagnosed with schizophrenia
  • Based on the patient's clinical status, new or change of antipsychotic treatment is indicated
  • The patient is at least 18 years of age
  • The patient meets the criteria set out in the national SPCs for sertindole and risperidone. For those countries in which sertindole was not marketed, the EU SPC applied

Exclusion

  • The last treatment taken by the patient was sertindole or risperidone
  • The patient has never previously received any antipsychotic drug therapy
  • The patient has contraindications to treatment with either sertindole or risperidone
  • In addition to sertindole/risperidone, treatment with another antipsychotic is indicated
  • The patient is homeless
  • The patient has previously been included in one of the two H. Lundbeck A/S post-marketing studies, 99823 or 99824
  • The patient is, in the opinion of the investigator, unlikely to comply with the study protocol or unsuitable for any other reason

Key Trial Info

Start Date :

July 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2008

Estimated Enrollment :

9809 Patients enrolled

Trial Details

Trial ID

NCT00856583

Start Date

July 1 2002

End Date

February 1 2008

Last Update

August 19 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.